Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€20.53
14.03.22
€14.00
14.03.23
3.70%
16.03.22

Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
geldnutzer 
14.03.22 60%
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€4.81
14.03.22
€6.40
14.03.23
-33.68%
11.06.22

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
geldnutzer 
14.03.22 50%
sell
Gensight Biologics SA

Start price
Target price
Perf. (%)
€2.97
07.03.22
-
07.03.23
-19.53%
08.03.23

Risky Investment
Lokrim 
07.03.22 20%
sell
Innate Pharma

Start price
Target price
Perf. (%)
€2.51
07.03.22
-
07.03.23
21.39%
08.03.23

Probably not worthwhile Investment
Lokrim 
07.03.22 20%
sell
QIAGEN NV

Start price
Target price
Perf. (%)
€40.90
07.03.22
-
07.03.25
2.08%
11.03.24

Probably not worthwhile Investment
Lutz69 
07.03.22 50%
sell
QIAGEN NV

Start price
Target price
Perf. (%)
€40.90
07.03.22
-
07.03.25
2.08%
11.03.24

Probably not worthwhile Investment
Lutz69 
07.03.22 50%
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€13.20
06.03.22
-
06.03.23
17.35%
17.03.22

Risky Investment
thomasw 
06.03.22 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€150.38
02.03.22
-
02.03.23
-4.80%
03.03.23

AlleAktien 
02.03.22 0%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€150.38
02.03.22
-
02.03.23
-4.80%
03.03.23

AlleAktien 
02.03.22 0%
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€24.31
01.03.22
€30.00
01.04.22
4.07%
02.04.22

Could be worthwhile Investment >10% per year
melinda 
01.03.22 50%
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€24.31
01.03.22
€30.00
01.04.22
4.07%
02.04.22

Could be worthwhile Investment >10% per year
melinda 
01.03.22 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€52.40
01.03.22
-
01.03.23
2.48%
02.03.22

Mori8 
01.03.22 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€52.40
01.03.22
-
01.03.23
2.48%
02.03.22

Mori8 
01.03.22 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€14.57
01.03.22
-
01.03.23
-43.77%
02.03.23

Saftman 
01.03.22 50%
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€4.14
26.02.22
-
26.02.23
-59.29%
27.10.22

Could be very worthwhile Investment >20% year
ngapali 
26.02.22 50%
buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€1.03
22.02.22
€1.00
22.02.23
-25.24%
05.03.22

Could be worthwhile Investment >10% per year
Capable Management
Bad culture
me8 
22.02.22 0%
sell
Novavax Inc.

Start price
Target price
Perf. (%)
€65.99
21.02.22
-
21.01.26
-92.38%
11.03.24

Probably not worthwhile Investment
Lutz69 
21.02.22 50%
buy
Aclaris Therapeutics Inc

Start price
Target price
Perf. (%)
€11.54
21.02.22
€15.00
21.02.23
2.90%
22.02.23

Could be worthwhile Investment >10% per year
melinda 
21.02.22 50%
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.015
20.02.22
€7.50
20.03.22
61900.00%
21.03.22

Could be worthwhile Investment >10% per year
melinda 
20.02.22 50%
buy
Agios Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€25.74
20.02.22
€30.00
20.03.22
2.76%
21.03.22

Could be worthwhile Investment >10% per year
melinda 
20.02.22 50%
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€2.31
20.02.22
-
20.02.23
-6.49%
05.03.22

Risky Investment
bundfuture 
20.02.22 50%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€29.39
20.02.22
-
20.02.23
-0.65%
05.03.22

Could be very worthwhile Investment >20% year
blaugold 
20.02.22 50%
buy
Poxel S.A.

Start price
Target price
Perf. (%)
€3.04
20.02.22
€4.00
20.03.22
-11.39%
21.03.22

Could be worthwhile Investment >10% per year
melinda 
20.02.22 50%
sell
Aphria Inc.

Start price
Target price
Perf. (%)
€12.71
20.02.22
€13.00
20.02.23
-
17.03.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
20.02.22 60%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€6.85
20.02.22
-
20.02.23
-14.37%
05.03.22

Could be very worthwhile Investment >20% year
thomasw 
20.02.22 50%